Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis, CMS Continue To Talk On Visudyne Macular Degeneration Coverage

Mar 18 2002

• By The Pink Sheet

Related Content

Novartis/QLT Visudyne Expanded Indications Cover Up To 250,000 Patients

Aug 27 2001

Ciba Vision/QLT Visudyne Will Have Average Annual Cost of $4,175/Patient

Apr 17 2000

Novartis/QLT Visudyne Medicare Coverage Expansion Awaits More Data

Nov 12 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window